VANDAELE PHARMA
Board
2 directors, last change in 2020HAKAPHAR BV
Director, permanent representative VANDAELE Karel Jan Bernard
since 06-10-2020
term without a fixed end
listed in the 2025 annual accounts, filed on 18-03-2026
Permanent representatives 1
Mandates through the years
3 names, the dashed line is todayBoardEarliermandate already running before its first mention
Mandates as a list
- VANDAELE GUIDO BV
- Director, from 01-01-2015 to date
- HAKAPHAR
- Director, from 06-10-2020 to date
- VANDENHENDE Jan Medard Albert
- Director, until 23-10-2020
Control
Parent
Equity €668,384
Profit €82,164 in 2025 (profit €84,679 in 2024)
Checked score 93
Source: accounts HAKAPHAR 30-06-2025
90%
This company
VANDAELE PHARMA
Equity €320,048
Profit €53,941 in 2025
Capital
- Contribution
- €18,600
- Source
- 2025 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- HAKAPHAR
Source: lists of holdings in the owners' accounts
Articles of association
deed of 23-10-2020 (in Dutch)- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Thursday of February